Multifunctional targets of dietary polyphenols in disease: A case for the chemokine network and energy metabolism

Food and Chemical Toxicology

Volumn 51, Issue 1, 2013, Pages 267-279

  Joven, J ^a   Rull, A ^a   Rodriguez Gallego, E ^a   Camps, J ^a   Riera Borrull, M ^a   Hernandez Aguilera A ^a   Martin Paredero, V ^a   Segura Carretero, A ^b   Micol, V ^c   Alonso Villaverde, C ^a   Menendez J A ^d  

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

Author keywords

AMPK; Immune response; Inflammation; Macrophage; Oxidation; Toxicity

Indexed keywords

ADALIMUMAB; ANTINEOPLASTIC AGENT; CANAKINUMAB; CELASTROL; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; ETANERCEPT; FLAVONOID; GLYCYRRHIZIC ACID; HISTONE DEACETYLASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INFLIXIMAB; INSULIN; LIPID; MAMMALIAN TARGET OF RAPAMYCIN; MARAVIROC; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTIBODY; OLEUROPEIN; PARACETAMOL; PLERIXAFOR; POLYPHENOL DERIVATIVE; PROTEIN ANTIBODY; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RESVERATROL; SAPONIN DERIVATIVE; TRIPTOLIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; USTEKINUMAB;

AGING; ASTHMA; ATHEROSCLEROSIS; AUTOPHAGY; CALORIC RESTRICTION; CELL METABOLISM; CHRONIC INFLAMMATION; DEPRESSION; DIET SUPPLEMENTATION; DISEASES; ENERGY METABOLISM; ENZYME ACTIVITY; EPIGENETICS; FAT INTAKE; FOOD COMPOSITION; FOOD DRUG INTERACTION; GENETIC REGULATION; HORMESIS; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFLAMMATORY CELL; INFLAMMATORY DISEASE; LIPID BLOOD LEVEL; LONGEVITY; MACROPHAGE MIGRATION; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; METABOLIC STRESS; MITOCHONDRIAL RESPIRATION; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SANITATION; SIGNAL TRANSDUCTION; TISSUE INJURY;

AMP-ACTIVATED PROTEIN KINASES; ATHEROSCLEROSIS; AUTOPHAGY; CHEMOKINE CCL2; CHEMOKINES; DIET; ENERGY METABOLISM; HUMANS; INFLAMMASOMES; INFLAMMATION; MACROPHAGES; NEOPLASMS; OBESITY; OXIDATIVE STRESS; POLYPHENOLS; TOR SERINE-THREONINE KINASES;

EID: 84868257897     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.10.004     Document Type: Review

References (172)

1. Abraham K., Wöhrlin F., Lindtner O., Heinemeyer G., Lampen A. Toxicology and risk assessment of coumarin: focus on human data. Mol. Nutr. Food Res. 2010, 54:228-239.
2. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., Mukhtar H. Green tea constituent epigallocatechin-3-gallate, and induction of cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 1997, 89:1881-1886.
3. Allavena P., Sica A., Solinas G., Porta C., Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 2008, 66:1-9.
4. Balkwill F., Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics. Clin. Pharmacol. Ther. 2010, 87:401-406.
5. Bandyopadhyay S., Zhan R., Chaudhuri A., Watabe M., Pai S.K., Hirota S., Hosobe S., Tsukada T., Miura K., Takano Y., Saito K., Pauza M.E., Hayashi S., Wang Y., Mohinta S., Mashimo T., Iiizumi M., Furuta E., Watabe K. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat. Med. 2006, 12:933-938.
6. Beltran-Debon R., Alonso-Villaverde C., Aragones G., Rodriguez-Medina I., Rull A., Micol V., Segura-Carretero A., Fernández-Gutiérrez A., Camps J., Joven J. The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans. Phytomedicine 2010, 17:186-191.
7. Beltran-Debon R., Rull A., Rodriguez-Sanabria F., Iswaldi I., Herranz-Lopez M., Aragones G., Camps J., Alonso-Villaverde C., Menéndez J.A., Micol V., Segura-Carretero A., Joven J. Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice. Phytomedicine 2011, 2011(18):414-424.
8. Blagosklonny M.V. Hormesis does not make sense except in the light of TOR-driven aging. Aging 2011, 3:1051-1062.
9. Blajecka K., Borgstrom A., Arcaro A. Phosphatidylinositol 3-kinase isoforms as novel drug targets. Curr. Drug. Targets 2011, 12:1056-1081.
10. Bonnard C., Durand A., Vidal H., Rieusset J. Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice. Diab. Metab. 2008, 34:52-61.
11. Broekhuizen L.N., van Wijk D.F., Vink H., Stalmach A., Crozier A., Hutten B.A., Kastelein J.J., Hugenholtz P.G., Koenig W., Stroes E.S. Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors. Br. J. Nutr. 2011, 106:1416-1422.
12. Calabrese E.J., Mattson M.P. Hormesis provides a generalized quantitative estimate of biological plasticity. J. Cell. Commun. Signal. 2011, 5:25-38.
13. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Iavicoli I., Di Paola R., Koverech A., Cuzzocrea S., Rizzarelli E., Calabrese E.J. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim. Biophys. Acta 2012, 1822:753-783.
14. Caligiuri A., Bertolani C., Guerra C.T., Aleffi S., Galastri S., Trappoliere M., Vizzutti F., Gelmini S., Laffi G., Pinzani M., Marra F. Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology 2008, 47:668-676.
15. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., Chen R.O., Brownstein B.H., Cobb J.P., Tschoeke S.K., Miller-Graziano C., Moldawer L.L., Mindrinos M.N., Davis R.W., Tompkins R.G., Lowry S.F. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037.
16. Camps J., Marsillach J., Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit. Rev. Clin. Lab. Sci. 2009, 46:83-106.
17. Caturla N., Pérez-Fons L., Estepa A., Micol V. Differential effects of oleuropein, a biophenol from Olea europaea, on anionic and zwiterionic phospholipid model membranes. Chem. Phys. Lipids. 2005, 137:2-17.
18. Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signalling-dependent apoptosis in human tumor cells. Blood 1998, 92:996-1002.
19. Coll B., Alonso-Villaverde C., Joven J. Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker?. Clin. Chim. Acta 2007, 383:21-29.
20. Coll B., Parra S., Alonso-Villaverde C., Aragones G., Montero M., Camps J., Joven J., Masana L. The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke 2007, 38:2477-2484.
21. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
22. Conti I., Rollins B.J. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin. Cancer Biol. 2004, 14:149-154.
23. Corominas-Faja B., Quirantes-Piné R., Oliveras-Ferraros C., Vazquez-Martin A., Cufí S., Martin-Castillo B., Micol V., Joven J., Segura-Carretero A., Menendez J.A. Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging (Albany NY) 2012, 4:480-498.
24. Cufi S., Vazquez-Martin A., Oliveras-Ferraros C., Martin-Castillo B., Joven J., Menendez J.A. Metformin against TGFbeta-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cell Cycle 2010, 9:4461-4468.
25. Charo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ. Res. 2004, 95:858-866.
26. Chen L.J., Lebetkin E.H., Burka L.T. Comparative disposition of (R)-(+)-pulegone in B6C3F1 mice and F344 rats. Drug Metab. Dispos. 2003, 31:892-899.
27. Chen Y., Azad M.B., Gibson S.B. Superoxide is the major reactive oxygen species regulating autophagy. Cell. Death Differ. 2009, 16:1040-1052.
28. Choi K.W., Um S.H., Kwak J.H., Park H.J., Kim K.H., Moon E.Y., Kwon S.T., Pyo S. Suppression of adhesion molecule expression by phenanthrene-containing extract of bulbils of Chinese Yam in vascular smooth muscle cells through inhibition of MAPK, Akt and NF-κB. Food Chem. Toxicol. 2012, 50:2792-2804.
29. Chow F.Y., Nikolic-Paterson D.J., Ozols E., Atkins R.C., Rollin B.J., Tesch G.H. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 2006, 69:73-80.
30. Chuang C.C., McIntosh M.K. Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases. Annu. Rev. Nutr. 2011, 31:155-176.
31. + T cells. J. Exp. Med. 2003, 197:1017-1028.
32. de Waard V., Bot I., de Jager S.C., Talib S., Egashira K., de Vries M.R., Quax P.H., Biessen E.A., van Berkel T.J. Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently. Atherosclerosis 2010, 211:84-89.
33. Declèves A.E., Mathew A.V., Cunard R., Sharma K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 2011, 22:1846-1855.
34. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., Ranganathan G., Peterson C.A., McGehee R.E., Kern P.A. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005, 54:2305-2313.
35. Dias M.C., Vieiralves N.F., Gomes M.I., Salvadori D.M., Rodrigues M.A., Barbisan L.F. Effects of lycopene, synbiotic and their association on early biomarkers of rat colon carcinogenesis. Food Chem. Toxicol. 2010, 48:772-780.
36. Dinarello C.A. Anti-inflammatory agents: present and future. Cell 2010, 140:935-950.
37. Druckova A., Mernaugh R.L., Ham A.J., Marnett L.J. Identification of the protein targets of the reactive metabolite of teucrin A in vivo in the rat. Chem. Res. Toxicol. 2007, 20:1393-1408.
38. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nuñez G., Schnurr M., Espevik T., Lien E., Fitzgerald K.A., Rock K.L., Moore K.J., Wright S.D., Hornung V., Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
39. Efferth T., Koch E. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Targets 2011, 12:122-132.
40. Egan D.F., Shackelford D.B., Mihaylova M.M., Gelino S., Kohnz R.A., Mair W., Vasquez D.S., Joshi A., Gwinn D.M., Taylor R., Asara J.M., Fitzpatrick J., Dillin A., Viollet B., Kundu M., Hansen M., Shaw R.J. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331:456-461.
41. Engelman J.A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 2009, 9:550-562.
42. Evans J.M., Donnelly L.A., Emslie-Smith A.M., Alessi D.R., Morris A.D. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005, 330:1304-1305.
43. Ewart M.A., Kohlhaas C.F., Salt I.P. Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2255-2257.
44. Fernández-Arroyo S., Herranz-López M., Beltrán-Debón R., Borrás-Linares I., Barrajón-Catalán E., Joven J., Fernández-Gutiérrez A., Segura-Carretero A., Micol V. Bioavailability study of a polyphenol-enriched extract from Hibiscus sabdariffa in rats and associated antioxidant status. Mol. Nutr. Food Res. 2012, 10.1002/mnfr.201200091.
45. Ferré N., Martínez-Clemente M., López-Parra M., González-Périz A., Horrillo R., Planagumà A., Camps J., Joven J., Tres A., Guardiola F., Bataller R., Arroyo V., Clària J. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice. Potential involvement of oxysterols. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G553-G562.
46. Fingar D.C., Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004, 23:3151-3171.
47. Fujimoto H., Sangai T., Ishii G., Ikehara A., Nagashima T., Miyazaki M., Ochiai A. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int. J. Cancer 2009, 125:1276-1284.
48. García-Villalba R., Carrasco-Pancorbo A., Oliveras-Ferraros C., Menéndez J.A., Segura-Carretero A., Fernández-Gutiérrez A. Uptake and metabolism of olive oil polyphenols in human breast cancer cells using nano-liquid chromatography coupled to electrospray ionization-time of flight-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 898:69-77.
49. Gerard C., Rollins B.J. Chemokines and disease. Nat. Immunol. 2001, 2:108-115.
50. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
51. Hadi S.M., Bhat S.H., Azmi A.S., Hanif S., Shamim U., Ullah M.F. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin. Cancer Biol. 2007, 17(5):370-376.
52. Hardie D.G. The AMP-activated protein kinase pathway - new players upstream and downstream. J. Cell. Sci. 2004, 117:5479-5487.
53. Hardie D.G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes. Dev. 2011, 25:1895-1908.
54. Haringman J.J., Gerlag D.M., Smeets T.J., Baeten D., van den Bosch F., Bresnihan B., Breedveld F.C., Dinant H.J., Legay F., Gram H., Loetscher P., Schmouder R., Woodworth T., Tak P.P. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis. Rheum. 2006, 54:2387-2392.
55. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
56. Hattori Y., Suzuki K., Hattori S., Kasai K. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006, 47:1183-1188.
57. Hattori Y., Nakano Y., Hattori S., Tomizawa A., Inukai K., Kasai K. High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Lett. 2008, 582:1719-1724.
58. Hattori Y., Suzuki K., Tomizawa A., Hirama N., Okayasu T., Hattori S., Satoh H., Akimoto K., Kasai K. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Cardiovasc. Res. 2009, 81:133-139.
59. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002, 96:67-202.
60. Hawley S.A., Fullerton M.D., Ross F.A., Schertzer J.D., Chevtzoff C., Walker K.J., Peggie M.W., Zibrova D., Green K.A., Mustard K.J., Kemp B.E., Sakamoto K., Steinberg G.R., Hardie D.G. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 2012, 336:918-922.
61. Henin N., Vincent M.F., Gruber H.E., Van den Berghe G. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 1995, 9:541-546.
62. Herranz-Lopez M., Fernandez-Arroyo S., Perez-Sanchez A., Barrajon-Catalan E., Beltran-Debon R., Menendez J.A., Alonso-Villaverde C., Segura-Carretero A., Joven J., Micol V. Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine 2012, 19:253-261.
63. Hildenbrand R., Allgayer H., Marx A., Stroebel P. Modulators of the urokinase-type plasminogen activation system for cancer. Expert. Opin. Investig. Drugs 2010, 19:641-652.
64. Hopkins A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 2008, 4:682-690.
65. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95:2409-2415.
66. Hwang J.T., Kwon D.Y., Yoon S.H. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N. Biotechnol. 2009, 26:17-22.
67. Igata M., Motoshima H., Tsuruzoe K., Kojima K., Matsumura T., Kondo T., Taguchi T., Nakamaru K., Yano M., Kukidome D., Matsumoto K., Toyonaga T., Asano T., Nishikawa T., Araki E. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ. Res. 2005, 97:837-844.
68. Inoue M., Suzuki R., Koide T., Sakaguchi N.T., Ogihara Y., Yabu Y. Antioxidant, gallic acid, induces apoptosis in HL60RG cells. Biochem. Biophys. Res. Commun. 1994, 204:898-904.
69. Iwabu M., Yamauchi T., Okada-Iwabu M., Sato K., Nakagawa T., Funata M., Yamaguchi M., Namiki S., Nakayama R., Tabata M., Ogata H., Kubota N., Takamoto I., Hayashi Y.K., Yamauchi N., Waki H., Fukayama M., Nishino I., Tokuyama K., Ueki K., Oike Y., Ishii S., Hirose K., Shimizu T., Touhara K., Kadowaki T. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010, 464:1313-1319.
70. Jamieson T., Cook D.N., Nibbs R.J., Rot A., Nixon C., McLean P., Alcami A., Lira S.A., Wiekowski M., Graham G.J. The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 2005, 6:403-411.
71. Jarde T., Perrier S., Vasson M.P., Caldefie-Chezet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur. J. Cancer. 2011, 47:33-43.
72. Jeong H.W., Hsu K.C., Lee J.W., Ham M., Huh J.Y., Shin H.J., Kim W.S., Kim J.B. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E955-E964.
73. Joven J., Espinel E., Rull A., Aragonès G., Rodríguez-Gallego E., Camps J., Herranz-López M., Menéndez J.A., Borrás I., Segura-Carretero A., Alonso-Villaverde C., Beltrán-Debón R. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim. Biophys. Acta 2012, 1820:894-899.
74. Kanellis J., Kandane R.K., Etemadmoghadam D., Fraser S.A., Mount P.F., Levidiotis V., Kemp B.E., Power D.A. Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells. Immunol. Cell. Biol. 2006, 84:6-12.
75. Kang C., Jin Y.B., Lee H., Cha M., Sohn E.T., Moon J., Park C., Chun S., Jung E.S., Hong J.S., Kim S.B., Kim J.S., Kim E. Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food Chem. Toxicol. 2010, 48:509-516.
76. Kang Y.S., Cha J.J., Hyun Y.Y., Cha D.R. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments. Expert. Opin. Investig. Drugs 2011, 20:745-756.
77. Keith C.T., Borisy A.A., Stockwell B.R. Multicomponent therapeutics for networked systems. Nat Rev Drug Discov. 2005, 4:71-78.
78. Khandekar M.J., Cohen P., Spiegelman B.M. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer. 2011, 11:886-895.
79. Kim H.J., Kim K.W., Yu B.P., Chung H.Y. The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic. Biol. Med. 2000, 28:683-692.
80. Kimura Y., Ito H., Ohnishi R., Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem. Toxicol. 2010, 48:429-435.
81. Kitamoto S., Egashira K. Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases. Expert. Rev. Cardiovasc. Ther. 2003, 1:393-400.
82. Ko H.J., Zhang Z., Jung D.Y., Jun J.Y., Ma Z., Jones K.E., Chan S.Y., Kim J.K. Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart. Diabetes 2009, 58:2536-2546.
83. Koenen R.R., Weber C. Chemokines: established and novel targets in atherosclerosis. EMBO Mol. Med. 2011, 3:713-725.
84. Koh K.K., Han S.H., Quon M.J. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J. Am. Coll. Cardiol. 2005, 46:1978-1985.
85. Kostyuk V.A., Potapovich A.I., Suhan T.O., de Luca C., Korkina L.G. Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation. Eur. J. Pharmacol. 2011, 658:248-256.
86. Kuo M.L., Huang T.S., Lin J.K. Curcumin, an antioxidant and antitumor promoter, induces apoptosis in human leukemia cells. Biochem. Biophys. Acta 1996, 1317:95-100.
87. Kuscher K., Danelon G., Paoletti S., Stefano L., Schiraldi M., Petkovic V., Locati M., Gerber B.O., Uguccioni M. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes. Eur. J. Immunol. 2009, 39:1118-1128.
88. Kwon E.Y., Do G.M., Cho Y.Y., Park Y.B., Jeon S.M., Choi M.S. Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: comparison with clofibrate. Food Chem. Toxicol. 2010, 48:2298-2303.
89. Lambernd S., Taube A., Schober A., Platzbecker B., Görgens S.W., Schlich R., Jeruschke K., Weiss J., Eckardt K., Eckel J. Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways. Diabetologia 2012, 55:1128-1139.
90. Lee S.H., Liu Y.T., Chen K.M., Lii C.K., Liu C.T. Effect of garlic sulfur compounds on neutrophil infiltration and damage to the intestinal mucosa by endotoxin in rats. Food Chem. Toxicol. 2012, 50:567-574.
91. Lehár J., Krueger A.S., Avery W., Heilbut A.M., Johansen L.M., Price E.R., Rickles R.J., Short G.F., Staunton J.E., Jin X., Lee M.S., Zimmermann G.R., Borisy A.A. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat. Biotechnol. 2009, 27:659-666.
92. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
93. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
94. Lim J.H., Kwon T.K. Curcumin inhibits phorbol myristate acetate (PMA)-induced MCP-1 expression by inhibiting ERK and NF-kappaB transcriptional activity. Food Chem. Toxicol. 2010, 48:47-52.
95. Lindholm C.R., Ertel R.L., Bauwens J.D., Schmuck E.G., Mulligan J.D., Saupe K.W. A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats. J. Physiol. Biochem. 2012, 10.1007/s13105-012-0199-2.
96. Little P.J., Chait A., Bobik A. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Pharmacol. Ther. 2011, 131:255-268.
97. Lluís L., Muñoz M., Nogués M.R., Sánchez-Martos V., Romeu M., Valls J., Solà R. Toxicology evaluation of a procyanidin-rich extract from grape skins and seeds. Food Chem. Toxicol. 2011, 49:1450-1454.
98. Long Y.C., Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 2006, 116:1776-1783.
99. López-Carrillo L., Camargo M.C., Schneider B.G., Sicinschi L.A., Hernández-Ramírez R.U., Correa P., Cebrian M.E. Capsaicin consumption, Helicobacter pylori CagA status and IL1B-31C>T genotypes: a host and environment interaction in gastric cancer. Food Chem. Toxicol. 2012, 50:2118-2222.
100. Lutgens E., Faber B., Schapira K., Evelo C.T., van Haaften R., Heeneman S., Cleutjens K.B., Bijnens A.P., Beckers L., Porter J.G., Mackay C.R., Rennert P., Bailly V., Jarpe M., Dolinski B., Koteliansky V., de Fougerolles T., Daemen M.J. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. Circulation 2005, 111:3443-3452.
101. Maestre R., Micol V., Funes L., Medina I. Incorporation and interaction of grape seed extract in membranes and relation with efficacy in muscle foods. J. Agric. Food. Chem. 2010, 58:8365-8374.
102. Mantovani A. Molecular pathways linking inflammation and cancer. Curr. Mol. Med. 2010, 10:369-373.
103. Mantovani A., Bonecchi R., Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 2006, 6:907-918.
104. Martin-Castillo B., Vazquez-Martin A., Oliveras-Ferraros C., Menendez J.A. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle 2010, 9:1057-1064.
105. McVean G., Spencer C.C., Chaix R. Perspectives on human genetic variation from the HapMap Project. PLoS Genet. 2005, 1:e54.
106. Menendez J.A., Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007, 7:763-777.
107. Menendez J.A., Cufi S., Oliveras-Ferraros C., Vellon L., Joven J., Vazquez-Martin A. Gerosuppressant metformin: less is more. Aging (Albany NY) 2011, 3:348-362.
108. Menendez J.A., Vellon L., Oliveras-Ferraros C., Cufi S., Vazquez-Martin A. MTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell. Cycle 2011, 10:3658-3677.
109. Menendez J.A., Oliveras-Ferraros C., Cufí S., Corominas-Faja B., Joven J., Martin-Castillo B., Vazquez-Martin A. Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 2012, 11:2782-2792.
110. Mikstacka R., Przybylska D., Rimando A.M., Baer-Dubowska W. Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol. Nutr. Food Res. 2007, 51:517-524.
111. 120 but reduces MCP-1 release in mature 3T3-L1 adipocytes: possible regulatory mechanism through endogenous ER stress and AMPK-related pathways. Biochem. Biophys. Res. Commun. 2012, 419:200-205.
112. Morel O., Hugel B., Jesel L., Lanza F., Douchet M.P., Zupan M., Chauvin M., Cazenave J.P., Tedgui A., Freyssinet J.M., Toti F. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb. Haemost. 2004, 91:345-353.
113. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
114. Murakami A., Ohnishi K. Target molecules of food phytochemicals: food science bound for the next dimension. Food Funct. 2012, 3:462-476.
115. Navarro-Gonzalez J.F., Mora-Fernandez C., Muros de Fuentes M., Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol. 2011, 7:327-340.
116. Niu J., Kolattukudy P.E. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. (Lond) 2009, 117:95-109.
117. Oliveras-Ferraros C., Fernandez-Arroyo S., Vazquez-Martin A., Lozano-Sanchez J., Cufi S., Joven J., Micol V., Fernández-Gutiérrez A., Segura-Carretero A., Menendez J.A. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3. Int. J. Oncol. 2011, 38:1533-1547.
118. Paul A., Calleja L., Camps J., Osada J., Vilella E., Ferre N., Mayayo E., Joven J. The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice. Life Sci. 2000, 68:457-465.
119. Porta C., Rimoldi M., Raes G., Brys L., Ghezzi P., Di Liberto D., Dieli F., Ghisletti S., Natoli G., De Baetselier P., Mantovani A., Sica A. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. USA 2009, 106:14978-14983.
120. Qian B.Z., Li J., Zhang H., Kitamura T., Zhang J., Campion L.R., Kaiser E.A., Snyder L.A., Pollard J.W. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475:222-225.
121. Raes G., Van den Bergh R., De Baetselier P., Ghassabeh G.H., Scotton C., Locati M., Mantovani A., Sozzani S. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 2005, 174:6561-6562.
122. Ristow M., Schmeisser S. Extending life span by increasing oxidative stress. Free Radic. Biol. Med. 2011, 51:327-336.
123. Roberts D.L., Dive C., Renehan A.G. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu. Rev. Med. 2010, 61:301-316.
124. Roca H., Varsos Z.S., Pienta K.J. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells. Neoplasia 2009, 11:1309-1317.
125. Rodriguez-Sanabria F., Rull A., Beltran-Debon R., Aragones G., Camps J., Mackness B., Mackness M., Joven J. Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role. J. Mol. Histol. 2010, 41:379-386.
126. Rollins B.J., Sunday M.E. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 1991, 11:3125-3131.
127. Rovin B.H., Lu L., Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 1999, 259:344-348.
128. Rozel S., Galban C.J., Nicolay K., Lee K.C., Sud S., Neeley C., Snyder L.A., Chenevert T.L., Rehemtulla A., Ross B.D., Pienta K.J. Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J. Cell. Biochem. 2009, 107:58-64.
129. Rozenberg O., Rosenblat M., Coleman R., Shih D.M., Aviram M. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic. Biol. Med. 2003, 34:774-784.
130. Rull, A., Camps, J., Alonso-Villaverde, C., Joven, J., 2010. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm. pii: 326580.
131. Rull A., Garcia R., Fernandez-Sender L., Beltran-Debon R., Aragones G., Alegret J.M., Alonso-Villaverde C., Mackness B., Mackness M., Camps J., Martin-Paredero V., Joven J. The role of combined assessment of defense against oxidative stress and inflammation in the evaluation of peripheral arterial disease. Curr. Mol. Med. 2011, 11:453-464.
132. Saji H., Koike M., Yamori T., Saji S., Seiki M., Matsushima K., Toi M. Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 2001, 92:1085-1091.
133. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., Oppenheim J.J., Murphy W.J. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000, 96:34-40.
134. Salminen W.F., Yang X., Shi Q., Greenhaw J., Davis K., Ali A.A. Green tea extract can potentiate acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 2012, 50:1439-1446.
135. Schmidt B., Ribnicky D.M., Poulev A., Logendra S., Cefalu W.T., Raskin I. A natural history of botanical therapeutics. Metabolism 2008, 57:S3-S9.
136. Schmeiser H.H., Stiborovà M., Arlt V.M. Chemical and molecular basis of the carcinogenicity of Aristolochia plants. Curr. Opin. Drug Discov. Develop. 2009, 12:141-148.
137. Schnabel R.B., Baumert J., Barbalic M., Dupuis J., Ellinor P.T., Durda P., et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2010, 115:5289-5299.
138. Siveen K.S., Kuttan G. Role of macrophages in tumour progression. Immunol. Lett. 2009, 123:97-102.
139. Smith R.L., Adams T.B., Doull J., Feron V.J., Goodman J.I., Marnett L.J., Portoghese P.S., Waddell W.J., Wagner B.M., Rogers A.E., Caldwell J., Sipes I.G. Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyl eugenol and estragole. Food Chem. Toxicol. 2002, 40:851-870.
140. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leuk. Biol. 2009, 86:1065-1073.
141. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
142. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009, 89:1025-1078.
143. Stienstra R., Tack C.J., Kanneganti T.D., Joosten L.A., Netea M.G. The inflammasome puts obesity in the danger zone. Cell Metab. 2012, 15:10-18.
144. Stupans I., Murray M., Kirlich A., Tuck K.L., Hayball P.J. Inactivation of cytochrome P450 by the food-derived complex phenol oleuropein. Food Chem. Toxicol. 2001, 39:1119-1124.
145. Sutherland L.N., Capozzi L.C., Turchinsky N.J., Bell R.C., Wright D.C. Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1076-E1083.
146. Tatewaki H., Egashira K., Kimura S., Nishida T., Morita S., Tominaga R. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J. Vasc. Surg. 2007, 45:1236-1243.
147. Tee A.R., Blenis J. MTOR, translational control and human disease. Semin. Cell Dev. Biol. 2005, 16:29-37.
148. Tilg H., Moschen A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 2008, 14:222-231.
149. Tomizawa A., Hattori Y., Kasai K. Induction of gene expression in response to globular adiponectin in vascular endothelial cells. Life Sci. 2009, 85:457-461.
150. Tous M., Ferré N., Vilella E., Riu F., Camps J., Joven J. Aspirin attenuates the initiation but not the progression of atherosclerosis in apolipoprotein E-deficient mice fed a high-fat, high-cholesterol diet. Basic Clin. Pharmacol. Toxicol. 2004, 95:15-19.
151. Tous M., Ferre N., Camps J., Riu F., Joven J. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol. Cell. Biochem. 2005, 268:53-58.
152. Tous M., Ribas V., Ferre N., Escola-Gil J.C., Blanco-Vaca F., Alonso-Villaverde C., Coll B., Camps J., Joven J. Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient mice. Biochim. Biophys. Acta 2005, 1733:192-198.
153. Tous M., Ferre N., Rull A., Marsillach J., Coll B., Alonso-Villaverde C., Camps J., Joven J. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem. Biophys. Res. Commun. 2006, 340:1078-1084.
154. Tripathi M., Singh B.K., Kakkar P. Glycyrrhizic acid modulates t-BHP induced apoptosis in primary rat hepatocytes. Food Chem. Toxicol. 2009, 47:339-347.
155. Ueno T., Toi M., Saji H., Muta M., Bando H., Kuroi K., Koike M., Inadera H., Matsushima K. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 2000, 6:3282-3289.
156. Valkovic T., Lucin K., Krstulja M., Dobi-Babic R., Jonjic N. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol. Res. Pract. 1998, 194:335-340.
157. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
158. Vazquez-Martin A., Lopez-Bonetc E., Cufi S., Oliveras-Ferraros C., Del Barco S., Martin-Castillo B., Menendez J.A. Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions. Drug Resist. Updat. 2011, 14:212-223.
159. Vitaglione P., Morisco F., Mazzone G., Amoruso D.C., Ribecco M.T., Romano A., Fogliano V., Caporaso N., D'Argenio G. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010, 52:1652-1661.
160. Walter S., Bottazzi B., Govoni D., Colotta F., Mantovani A. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 1991, 49:431-435.
161. Wang J., Ou Z.L., Hou Y.F., Luo J.M., Shen Z.Z., Ding J., Shao Z.M. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006, 2006(25):7201-7211.
162. Weiner O.D., Neilsen P.O., Prestwich G.D., Kirschner M.W., Cantley L.C., Bourne H.R. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat. Cell Biol. 2002, 4:509-513.
163. Wen H., Ting J.P., O'Neill L.A. A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation?. Nat. Immunol. 2012, 13:352-357.
164. Westerheide S.D., Anckar J., Stevens S.M., Sistonen L., Morimoto R.I. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 2009, 323:1063-1066.
165. Witte I., Foerstermann U., Devarajan A., Reddy S.T., Horke S. Protectors or traitors: the roles of PON2 and PON3 in atherosclerosis and cancer. J. Lipids. 2012, 2012:342806.
166. Wong S.C., Puaux A.L., Chittezhath M., Shalova I., Kajiji T.S., Wang X., Abastado J.P., Lam K.P., Biswas S.K. Macrophage polarization to a unique phenotype driven by B cells. Eur. J. Immunol. 2010, 40:2296-2307.
167. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
168. Wu F.Y., Ou Z.L., Feng L.Y., Luo J.M., Wang L.P., Shen Z.Z., Shao Z.M. Chemokine decoy receptor d6 plays a negative role in human breast cancer. Mol. Cancer Res. 2008, 6:1276-1288.
169. Wunderlich F.T., Luedde T., Singer S., Schmidt-Supprian M., Baumgartl J., Schirmacher P., Pasparakis M., Brüning J.C. Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proc. Natl. Acad. Sci. USA 2008, 105:1297-1302.
170. Yan Y.H., Shang P.Z., Lu Q.J., Wu X. Triptolide regulates T cell-mediated immunity via induction of CD11c(low) dendritic cell differentiation. Food Chem. Toxicol. 2012, 50:2560-2564.
171. Yang H.S., Kim J.Y., Lee J.H., Lee B.W., Park K.H., Shim K.H., Lee M.K., Seo K.I. Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells. Food Chem. Toxicol. 2011, 49:527-532.
172. Zhang J., Patel L., Pienta K.J. Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic. Prog. Mol. Biol. Transl. Sci. 2010, 95:31-53.